Canagliflozin Hemihydrate
💊 Brand Formulations & Prices
5 brands sorted by unit price
Canaglif
Canarol
Diacana
Glicana
Invokana
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesCanaglif is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
The recommended starting dose is 100 mg once daily, taken before the first meal of the day. Dose can be increased to 300 mg once daily who have CrCl>60 ml/min or who requires additional glycemic control. No dose adjustment is required for mild renal impairment. For moderate renal impairment (CrCl 45-60 ml/min) Canagliflozin 100 mg is recommended.
History of serious hypersensitivity reaction to Canagliflozin, severe renal impairment, End Stage Renal Disease (ESRD), or on dialysis patients.
The most common adverse reactions of Canaglif are female genital mycotic infections, urinary tract infection and increased urination. Other side effects of Canaglif include low blood pressure, increases potassium blood levels (hyperkalemia), low blood glucose and increases Low-Density Lipoprotein (LDL-C).
Not for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
Canagliflozin is an inhibitor of subtype-2 sodium-glucose co-transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter reduces the reabsorption of glucose from renal tubules, leading to more excretion of glucose in urine.